You just read:

Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol

News provided by

Amgen

Mar 28, 2020, 10:00 ET